Starts & Stops: Small Innovators Advance Bioresorbable Stents

Trials of new bioresorbable stents being developed by a number of privately-held companies were featured among the list of trial initiations in the last month, as recorded by Informa's Meddevicetracker.

While Abbott suffered a recent knockback when its Absorb bioresorbable stent – the first of its kind to get regulatory approval – failed to show long-term benefit over metallic drug-eluting...